Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs aimed toward expanding the horizons of cytokine-based immunotherapy, specifically for cancers where cure possibilities remain limited. Use the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Check out Our Pipeline https://financefeeds.com/cme-group-to-launch-brokertec-clob-for-cash-us-treasuries-in-q3-2025/